nodes	percent_of_prediction	percent_of_DWPC	metapath
Masoprocol—IGF1R—Parkinson's disease	0.828	1	CbGaD
Masoprocol—IGF1R—hindbrain—Parkinson's disease	0.00523	0.112	CbGeAlD
Masoprocol—IGF1R—embryo—Parkinson's disease	0.00327	0.0698	CbGeAlD
Masoprocol—IGF1R—brainstem—Parkinson's disease	0.003	0.064	CbGeAlD
Masoprocol—IGF1R—forebrain—Parkinson's disease	0.0029	0.0617	CbGeAlD
Masoprocol—IGF1R—cardiovascular system—Parkinson's disease	0.00245	0.0522	CbGeAlD
Masoprocol—CYP2J2—forebrain—Parkinson's disease	0.00196	0.0419	CbGeAlD
Masoprocol—CYP2J2—cardiovascular system—Parkinson's disease	0.00166	0.0354	CbGeAlD
Masoprocol—IGF1R—head—Parkinson's disease	0.00166	0.0353	CbGeAlD
Masoprocol—IGF1R—nervous system—Parkinson's disease	0.00157	0.0335	CbGeAlD
Masoprocol—IGF1R—central nervous system—Parkinson's disease	0.00151	0.0323	CbGeAlD
Masoprocol—IGF1R—cerebellum—Parkinson's disease	0.00148	0.0315	CbGeAlD
Masoprocol—LTB4R—brain—Parkinson's disease	0.00146	0.031	CbGeAlD
Masoprocol—CYP2J2—medulla oblongata—Parkinson's disease	0.00142	0.0302	CbGeAlD
Masoprocol—ALOX5—cardiovascular system—Parkinson's disease	0.00131	0.0279	CbGeAlD
Masoprocol—CYP2J2—midbrain—Parkinson's disease	0.0013	0.0276	CbGeAlD
Masoprocol—CYP2J2—spinal cord—Parkinson's disease	0.00126	0.027	CbGeAlD
Masoprocol—Isoprenaline—ADRBK1—Parkinson's disease	0.00121	0.163	CrCbGaD
Masoprocol—IGF1R—brain—Parkinson's disease	0.0012	0.0256	CbGeAlD
Masoprocol—CYP2J2—head—Parkinson's disease	0.00112	0.024	CbGeAlD
Masoprocol—Dopamine—DBH—Parkinson's disease	0.00109	0.147	CrCbGaD
Masoprocol—CYP19A1—forebrain—Parkinson's disease	0.00107	0.0228	CbGeAlD
Masoprocol—CYP2J2—nervous system—Parkinson's disease	0.00107	0.0227	CbGeAlD
Masoprocol—CYP2J2—central nervous system—Parkinson's disease	0.00103	0.0219	CbGeAlD
Masoprocol—CYP2J2—cerebellum—Parkinson's disease	0.001	0.0214	CbGeAlD
Masoprocol—L-DOPA—DDC—Parkinson's disease	0.000891	0.12	CrCbGaD
Masoprocol—ALOX5—head—Parkinson's disease	0.000885	0.0189	CbGeAlD
Masoprocol—ALOX5—nervous system—Parkinson's disease	0.000839	0.0179	CbGeAlD
Masoprocol—CYP2J2—brain—Parkinson's disease	0.000814	0.0174	CbGeAlD
Masoprocol—ALOX5—central nervous system—Parkinson's disease	0.000808	0.0172	CbGeAlD
Masoprocol—ALOX5—cerebellum—Parkinson's disease	0.00079	0.0168	CbGeAlD
Masoprocol—Dobutamine—COMT—Parkinson's disease	0.000757	0.102	CrCbGaD
Masoprocol—ALOX5—brain—Parkinson's disease	0.000642	0.0137	CbGeAlD
Masoprocol—CYP19A1—head—Parkinson's disease	0.000612	0.0131	CbGeAlD
Masoprocol—CYP19A1—nervous system—Parkinson's disease	0.00058	0.0124	CbGeAlD
Masoprocol—CYP19A1—central nervous system—Parkinson's disease	0.000559	0.0119	CbGeAlD
Masoprocol—CYP19A1—brain—Parkinson's disease	0.000444	0.00946	CbGeAlD
Masoprocol—Dopamine—MAOB—Parkinson's disease	0.000398	0.0536	CrCbGaD
Masoprocol—Dopamine—COMT—Parkinson's disease	0.00037	0.0498	CrCbGaD
Masoprocol—Dopamine—MAOA—Parkinson's disease	0.000279	0.0376	CrCbGaD
Masoprocol—L-DOPA—DRD3—Parkinson's disease	0.000278	0.0375	CrCbGaD
Masoprocol—Dopamine—HTR7—Parkinson's disease	0.000275	0.037	CrCbGaD
Masoprocol—L-DOPA—DRD1—Parkinson's disease	0.000273	0.0368	CrCbGaD
Masoprocol—CYP19A1—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000267	0.00227	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—IL1B—Parkinson's disease	0.000266	0.00226	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—CASP3—Parkinson's disease	0.000265	0.00225	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—HTR1A—Parkinson's disease	0.000264	0.00224	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—TAC1—Parkinson's disease	0.00026	0.00221	CbGpPWpGaD
Masoprocol—Dopamine—DRD3—Parkinson's disease	0.000258	0.0348	CrCbGaD
Masoprocol—CYP2J2—Biological oxidations—COMT—Parkinson's disease	0.000256	0.00217	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—DRD1—Parkinson's disease	0.000255	0.00217	CbGpPWpGaD
Masoprocol—CYP2J2—Biological oxidations—GSTP1—Parkinson's disease	0.000255	0.00216	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—GRK5—Parkinson's disease	0.000254	0.00216	CbGpPWpGaD
Masoprocol—CYP2J2—Biological oxidations—MAOA—Parkinson's disease	0.000254	0.00216	CbGpPWpGaD
Masoprocol—Dopamine—DRD1—Parkinson's disease	0.000254	0.0342	CrCbGaD
Masoprocol—CYP2J2—Metapathway biotransformation—COMT—Parkinson's disease	0.000253	0.00214	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000252	0.00214	CbGpPWpGaD
Masoprocol—CYP2J2—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000251	0.00213	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—GRM4—Parkinson's disease	0.000251	0.00213	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—INS—Parkinson's disease	0.000251	0.00213	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—IL1B—Parkinson's disease	0.000248	0.00211	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—DRD3—Parkinson's disease	0.000247	0.0021	CbGpPWpGaD
Masoprocol—Dopamine—SLC6A3—Parkinson's disease	0.00024	0.0324	CrCbGaD
Masoprocol—LTB4R—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00024	0.00204	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—VPS35—Parkinson's disease	0.000239	0.00203	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—PENK—Parkinson's disease	0.000238	0.00202	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000235	0.002	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—GSTA4—Parkinson's disease	0.000234	0.00199	CbGpPWpGaD
Masoprocol—CYP2J2—Biological oxidations—GSTM1—Parkinson's disease	0.000234	0.00199	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—IL6—Parkinson's disease	0.000234	0.00199	CbGpPWpGaD
Masoprocol—CYP2J2—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000231	0.00196	CbGpPWpGaD
Masoprocol—CYP19A1—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000231	0.00196	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—GRM4—Parkinson's disease	0.000228	0.00194	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—HTR7—Parkinson's disease	0.000224	0.0019	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—DRD2—Parkinson's disease	0.000224	0.0019	CbGpPWpGaD
Masoprocol—CYP19A1—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00022	0.00187	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—PDYN—Parkinson's disease	0.000218	0.00185	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PENK—Parkinson's disease	0.000216	0.00184	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—TNF—Parkinson's disease	0.000215	0.00183	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—TNF—Parkinson's disease	0.000215	0.00183	CbGpPWpGaD
Masoprocol—Dopamine—HTR1A—Parkinson's disease	0.000211	0.0284	CrCbGaD
Masoprocol—CYP19A1—Biological oxidations—MAOB—Parkinson's disease	0.000209	0.00177	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000206	0.00175	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—VPS35—Parkinson's disease	0.000203	0.00173	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—GRM5—Parkinson's disease	0.000203	0.00172	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—DGKQ—Parkinson's disease	0.000198	0.00168	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—GPR37—Parkinson's disease	0.000198	0.00168	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PDYN—Parkinson's disease	0.000198	0.00168	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—TNF—Parkinson's disease	0.000193	0.00164	CbGpPWpGaD
Masoprocol—L-DOPA—DRD2—Parkinson's disease	0.000192	0.0259	CrCbGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—IL1B—Parkinson's disease	0.000187	0.00159	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—GRM5—Parkinson's disease	0.000184	0.00156	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000181	0.00154	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—EDN1—Parkinson's disease	0.000179	0.00152	CbGpPWpGaD
Masoprocol—Dopamine—DRD2—Parkinson's disease	0.000179	0.0241	CrCbGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000176	0.0015	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000172	0.00146	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—GPR37—Parkinson's disease	0.000169	0.00143	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—DGKQ—Parkinson's disease	0.000169	0.00143	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ND3—Parkinson's disease	0.000166	0.00141	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—MCCC1—Parkinson's disease	0.000166	0.00141	CbGpPWpGaD
Masoprocol—IGF1R—IRS-related events triggered by IGF1R—IL6—Parkinson's disease	0.000166	0.00141	CbGpPWpGaD
Masoprocol—IGF1R—Insulin Signaling—MAPK8—Parkinson's disease	0.000163	0.00138	CbGpPWpGaD
Masoprocol—IGF1R—IGF1R signaling cascade—IL6—Parkinson's disease	0.000162	0.00137	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—RIT2—Parkinson's disease	0.000158	0.00135	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000157	0.00133	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—HTR2A—Parkinson's disease	0.000157	0.00133	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000156	0.00133	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—TALDO1—Parkinson's disease	0.000156	0.00133	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—OMD—Parkinson's disease	0.000156	0.00133	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—IL6—Parkinson's disease	0.000156	0.00132	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—CYP2D6—Parkinson's disease	0.000155	0.00132	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000154	0.00131	CbGpPWpGaD
Masoprocol—CYP19A1—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000153	0.0013	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—GRK5—Parkinson's disease	0.00015	0.00128	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000149	0.00127	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—MCCC1—Parkinson's disease	0.000148	0.00126	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ND3—Parkinson's disease	0.000148	0.00126	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—NDUFB11—Parkinson's disease	0.000148	0.00126	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—TAC1—Parkinson's disease	0.000147	0.00125	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—IL6—Parkinson's disease	0.000145	0.00123	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—DRD1—Parkinson's disease	0.000144	0.00123	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—CYP2E1—Parkinson's disease	0.000142	0.0012	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—MAPK8—Parkinson's disease	0.000142	0.0012	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GCH1—Parkinson's disease	0.000141	0.0012	CbGpPWpGaD
Masoprocol—CYP19A1—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00014	0.00119	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—DRD3—Parkinson's disease	0.00014	0.00119	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—OMD—Parkinson's disease	0.000139	0.00118	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—TALDO1—Parkinson's disease	0.000139	0.00118	CbGpPWpGaD
Masoprocol—L-DOPA—CYP2D6—Parkinson's disease	0.000136	0.0183	CrCbGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—TNF—Parkinson's disease	0.000136	0.00115	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—HTR1A—Parkinson's disease	0.000136	0.00115	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—GRM4—Parkinson's disease	0.000135	0.00114	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—RIT2—Parkinson's disease	0.000135	0.00114	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—TAC1—Parkinson's disease	0.000134	0.00113	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—NDUFB11—Parkinson's disease	0.000132	0.00112	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—DRD1—Parkinson's disease	0.000131	0.00111	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00013	0.00111	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00013	0.0011	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—GRK5—Parkinson's disease	0.000128	0.00108	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MAG—Parkinson's disease	0.000128	0.00108	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PENK—Parkinson's disease	0.000128	0.00108	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000127	0.00108	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—ABL1—Parkinson's disease	0.000127	0.00108	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—DRD3—Parkinson's disease	0.000127	0.00108	CbGpPWpGaD
Masoprocol—Dopamine—CYP2D6—Parkinson's disease	0.000126	0.017	CrCbGaD
Masoprocol—LTB4R—GPCR downstream signaling—HTR7—Parkinson's disease	0.000126	0.00107	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—DRD2—Parkinson's disease	0.000126	0.00107	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GCH1—Parkinson's disease	0.000126	0.00107	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—FBP1—Parkinson's disease	0.000126	0.00107	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—DBH—Parkinson's disease	0.000126	0.00107	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GBA—Parkinson's disease	0.000126	0.00107	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000118	0.00101	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—COMT—Parkinson's disease	0.000118	0.000998	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—GSTP1—Parkinson's disease	0.000117	0.000993	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PDYN—Parkinson's disease	0.000117	0.000992	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—MAOA—Parkinson's disease	0.000117	0.000991	CbGpPWpGaD
Masoprocol—CYP19A1—Metapathway biotransformation—COMT—Parkinson's disease	0.000116	0.000984	CbGpPWpGaD
Masoprocol—CYP19A1—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000115	0.00098	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—HTR7—Parkinson's disease	0.000115	0.000975	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—DRD2—Parkinson's disease	0.000115	0.000975	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—GRM4—Parkinson's disease	0.000115	0.000973	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000113	0.000964	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GBA—Parkinson's disease	0.000112	0.000952	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—DBH—Parkinson's disease	0.000112	0.000952	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—FBP1—Parkinson's disease	0.000112	0.000952	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—GFAP—Parkinson's disease	0.00011	0.000933	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—IL6—Parkinson's disease	0.00011	0.00093	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PENK—Parkinson's disease	0.000109	0.000922	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MAG—Parkinson's disease	0.000109	0.000922	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—GRM5—Parkinson's disease	0.000109	0.000922	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—GSTM1—Parkinson's disease	0.000108	0.000913	CbGpPWpGaD
Masoprocol—CYP19A1—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000106	0.0009	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—EDN1—Parkinson's disease	0.000101	0.000859	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PDYN—Parkinson's disease	9.94e-05	0.000844	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	9.64e-05	0.000819	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—FGF20—Parkinson's disease	9.53e-05	0.000809	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—GFAP—Parkinson's disease	9.34e-05	0.000793	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—GRM5—Parkinson's disease	9.24e-05	0.000784	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ADORA2A—Parkinson's disease	9.24e-05	0.000784	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—DDC—Parkinson's disease	9.24e-05	0.000784	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—EDN1—Parkinson's disease	9.19e-05	0.00078	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—HTR2A—Parkinson's disease	8.85e-05	0.000752	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GSTA4—Parkinson's disease	8.72e-05	0.000741	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	8.61e-05	0.000731	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—INSR—Parkinson's disease	8.52e-05	0.000724	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—DDC—Parkinson's disease	8.23e-05	0.000699	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FGF20—Parkinson's disease	8.1e-05	0.000688	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	8.1e-05	0.000687	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—FGB—Parkinson's disease	8.06e-05	0.000684	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—HTR2A—Parkinson's disease	8.04e-05	0.000683	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HTR1A—Parkinson's disease	8.01e-05	0.000681	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TAC1—Parkinson's disease	7.89e-05	0.00067	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ADORA2A—Parkinson's disease	7.85e-05	0.000667	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PLA2G6—Parkinson's disease	7.85e-05	0.000667	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GSTA4—Parkinson's disease	7.77e-05	0.00066	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—MAOB—Parkinson's disease	7.77e-05	0.00066	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—DRD1—Parkinson's disease	7.74e-05	0.000657	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	7.67e-05	0.000652	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—MCCC1—Parkinson's disease	7.62e-05	0.000647	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ND3—Parkinson's disease	7.62e-05	0.000647	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—DRD3—Parkinson's disease	7.5e-05	0.000637	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	7.4e-05	0.000628	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—INSR—Parkinson's disease	7.25e-05	0.000615	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—TALDO1—Parkinson's disease	7.17e-05	0.000609	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—OMD—Parkinson's disease	7.17e-05	0.000609	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ADRBK1—Parkinson's disease	7e-05	0.000594	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PLA2G6—Parkinson's disease	7e-05	0.000594	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—MAOB—Parkinson's disease	6.93e-05	0.000588	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FGB—Parkinson's disease	6.85e-05	0.000582	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HTR1A—Parkinson's disease	6.81e-05	0.000579	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NDUFB11—Parkinson's disease	6.79e-05	0.000577	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HTR7—Parkinson's disease	6.78e-05	0.000576	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—DRD2—Parkinson's disease	6.78e-05	0.000576	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TAC1—Parkinson's disease	6.71e-05	0.00057	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	6.59e-05	0.00056	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—DRD1—Parkinson's disease	6.58e-05	0.000559	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GCH1—Parkinson's disease	6.48e-05	0.00055	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—DRD3—Parkinson's disease	6.37e-05	0.000541	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—CASP3—Parkinson's disease	6.24e-05	0.00053	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ADRBK1—Parkinson's disease	5.95e-05	0.000505	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	5.85e-05	0.000496	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—FBP1—Parkinson's disease	5.78e-05	0.000491	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—DBH—Parkinson's disease	5.78e-05	0.000491	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP2D6—Parkinson's disease	5.78e-05	0.000491	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GBA—Parkinson's disease	5.78e-05	0.000491	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—DRD2—Parkinson's disease	5.76e-05	0.000489	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HTR7—Parkinson's disease	5.76e-05	0.000489	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IGF2—Parkinson's disease	5.68e-05	0.000482	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CTGF—Parkinson's disease	5.67e-05	0.000482	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IGF1R—Parkinson's disease	5.49e-05	0.000466	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—EDN1—Parkinson's disease	5.43e-05	0.000461	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP2E1—Parkinson's disease	5.28e-05	0.000449	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—NQO1—Parkinson's disease	5.22e-05	0.000444	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP2D6—Parkinson's disease	5.15e-05	0.000437	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—TH—Parkinson's disease	5.15e-05	0.000437	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CTGF—Parkinson's disease	5.05e-05	0.000429	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NGF—Parkinson's disease	4.99e-05	0.000424	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYCS—Parkinson's disease	4.94e-05	0.00042	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IGF2—Parkinson's disease	4.83e-05	0.00041	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HTR2A—Parkinson's disease	4.75e-05	0.000403	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP2E1—Parkinson's disease	4.71e-05	0.0004	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—NQO1—Parkinson's disease	4.66e-05	0.000395	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—EDN1—Parkinson's disease	4.62e-05	0.000392	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—TH—Parkinson's disease	4.59e-05	0.00039	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—APOE—Parkinson's disease	4.41e-05	0.000375	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYCS—Parkinson's disease	4.41e-05	0.000374	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—COMT—Parkinson's disease	4.38e-05	0.000372	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GSTP1—Parkinson's disease	4.36e-05	0.00037	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—MAOA—Parkinson's disease	4.35e-05	0.000369	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—HMOX1—Parkinson's disease	4.3e-05	0.000365	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NGF—Parkinson's disease	4.24e-05	0.00036	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—DDC—Parkinson's disease	4.24e-05	0.00036	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ABCB1—Parkinson's disease	4.12e-05	0.00035	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HTR2A—Parkinson's disease	4.04e-05	0.000343	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTA4—Parkinson's disease	4e-05	0.00034	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GSTM1—Parkinson's disease	4e-05	0.00034	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.95e-05	0.000336	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—COMT—Parkinson's disease	3.9e-05	0.000331	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GSTP1—Parkinson's disease	3.88e-05	0.00033	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—MAOA—Parkinson's disease	3.87e-05	0.000329	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GPX1—Parkinson's disease	3.83e-05	0.000326	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—HMOX1—Parkinson's disease	3.83e-05	0.000325	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—INS—Parkinson's disease	3.77e-05	0.00032	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—APOE—Parkinson's disease	3.75e-05	0.000319	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ABCB1—Parkinson's disease	3.68e-05	0.000312	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PLA2G6—Parkinson's disease	3.61e-05	0.000306	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GSTM1—Parkinson's disease	3.57e-05	0.000303	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—MAOB—Parkinson's disease	3.57e-05	0.000303	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—MTHFR—Parkinson's disease	3.54e-05	0.000301	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GPX1—Parkinson's disease	3.42e-05	0.00029	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.4e-05	0.000288	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—APOE—Parkinson's disease	3.29e-05	0.00028	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—INS—Parkinson's disease	3.21e-05	0.000272	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—MTHFR—Parkinson's disease	3.15e-05	0.000268	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—APOE—Parkinson's disease	2.94e-05	0.000249	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—INS—Parkinson's disease	2.81e-05	0.000239	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CASP3—Parkinson's disease	2.81e-05	0.000238	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—IL6—Parkinson's disease	2.79e-05	0.000237	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP2D6—Parkinson's disease	2.65e-05	0.000225	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CTGF—Parkinson's disease	2.6e-05	0.000221	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MAPK8—Parkinson's disease	2.58e-05	0.000219	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—INS—Parkinson's disease	2.51e-05	0.000213	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP2E1—Parkinson's disease	2.43e-05	0.000206	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NQO1—Parkinson's disease	2.4e-05	0.000204	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CASP3—Parkinson's disease	2.39e-05	0.000203	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—TH—Parkinson's disease	2.36e-05	0.000201	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYCS—Parkinson's disease	2.27e-05	0.000193	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MAPK8—Parkinson's disease	2.19e-05	0.000186	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—COMT—Parkinson's disease	2.01e-05	0.000171	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTP1—Parkinson's disease	2e-05	0.00017	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—MAOA—Parkinson's disease	2e-05	0.000169	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—HMOX1—Parkinson's disease	1.97e-05	0.000168	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ABCB1—Parkinson's disease	1.89e-05	0.000161	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTM1—Parkinson's disease	1.84e-05	0.000156	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GPX1—Parkinson's disease	1.76e-05	0.00015	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IL6—Parkinson's disease	1.65e-05	0.00014	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—MTHFR—Parkinson's disease	1.62e-05	0.000138	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—APOE—Parkinson's disease	1.51e-05	0.000128	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IL6—Parkinson's disease	1.4e-05	0.000119	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—INS—Parkinson's disease	1.29e-05	0.00011	CbGpPWpGaD
